Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2025-12-27 @ 1:15 PM
Study NCT ID:
NCT06255392
Status:
RECRUITING
Last Update Posted:
2025-08-15
First Post:
2024-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2031-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-03
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-05
First Submit QC Date:
None
Study First Post Date:
2024-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-12
Last Update Post Date:
2025-08-15
Last Update Post Date Type:
ACTUAL